Mackenzie Financial’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Mackenzie Financial’s Portfolio GBT Stock Details GBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-4,061	Closed	-$277K	–	1623
2022 Q3	$277K	Buy	+4,061	New	+$224K	﹤0.01%	1120
2020 Q2	–	Sell	-23,443	Closed	-$1.2M	–	1161
2020 Q1	$1.2M	Buy	+23,443	New	+$1.57M	﹤0.01%	606

Other funds holding GBT

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Mackenzie Financial's GBT Position: Q4 2022 in Review

Mackenzie Financial sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 4,061 shares — an estimated $277K sold.

Mackenzie Financial first reported a position in GBT in Q1 2020 and held it in 2 quarters. The position peaked at $1.2M in Q1 2020. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

Mackenzie Financial reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
Mackenzie Financial sold 4,061 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $277K.
Mackenzie Financial first reported a position in Global Blood Therapeutics, Inc. in Q1 2020 and held it in 2 quarters.
Mackenzie Financial's Global Blood Therapeutics, Inc. position peaked at $1.2M in Q1 2020.
2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on Mackenzie Financial's 13F filing for Q4 2022, filed 14 Feb 2023.